Cargando…

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries

BACKGROUND: There is a paucity of global data on cardiovascular disease (CVD) prevalence in people with type 2 diabetes (T2D). The primary objective of the CAPTURE study was to estimate the prevalence of established CVD and its management in adults with T2D across 13 countries from five continents....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosenzon, Ofri, Alguwaihes, Abdullah, Leon, Jose Luis Arenas, Bayram, Fahri, Darmon, Patrice, Davis, Timothy M. E., Dieuzeide, Guillermo, Eriksen, Kirsten T., Hong, Tianpei, Kaltoft, Margit S., Lengyel, Csaba, Rhee, Nicolai A., Russo, Giuseppina T., Shirabe, Shinichiro, Urbancova, Katerina, Vencio, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317423/ https://www.ncbi.nlm.nih.gov/pubmed/34315481 http://dx.doi.org/10.1186/s12933-021-01344-0

Ejemplares similares

Efficacy of liraglutide added to sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post‐hoc analysis of LIRA‐ADD2SGLT2i
por: Blonde, Lawrence, et al.
Publicado: (2021)

OR22-1 Liraglutide as Add-on to SGLT2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes (LIRA-ADD2SGLT2i): A 26-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Blonde, Lawrence, et al.
Publicado: (2019)

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial
por: Blonde, Lawrence, et al.
Publicado: (2020)

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
por: Mosenzon, Ofri, et al.
Publicado: (2013)

Early Insulinization to Prevent Diabetes Progression
por: Raz, Itamar, et al.
Publicado: (2013)

Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial
por: Schechter, Meir, et al.
Publicado: (2020)

Preventing all‐cause hospitalizations in type 2 diabetes with sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A narrative review and proposed clinical approach
por: Schechter, Meir, et al.
Publicado: (2022)

Effect of once‐weekly semaglutide versus thrice‐daily insulin aspart, both as add‐on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open‐label, multinational, phase 3b trial
por: Kellerer, Monika, et al.
Publicado: (2022)

Les nouvelles technologies : outils d'enseignement
por: Dieuzeide, Henri

Diabetes and Stroke: What Are the Connections?
por: Mosenzon, Ofri, et al.
Publicado: (2023)

Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials
por: Mosenzon, Ofri, et al.
Publicado: (2022)

What is important for people with type 2 diabetes? A focus group study to identify relevant aspects for Patient-Reported Outcome Measures in diabetes care
por: Abdel-Rahman, Nura, et al.
Publicado: (2022)

Multinational democracies /
Publicado: (2001)

Multinational corporations
Publicado: (1990)

The multinational corporation
por: Liebenau, Jonathan
Publicado: (1984)

Multinational Telecommunications
por: Collective
Publicado: (1977)

Between-Strain Competition in Acquisition and Clearance of Pneumococcal Carriage—Epidemiologic Evidence From a Longitudinal Study of Day-Care Children
por: Auranen, Kari, et al.
Publicado: (2010)

Critical Assessment of Clean-Up Techniques Employed in Simultaneous Analysis of Persistent Organic Pollutants and Polycyclic Aromatic Hydrocarbons in Fatty Samples
por: Drábová, Lucie, et al.
Publicado: (2022)

Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program
por: Lingvay, Ildiko, et al.
Publicado: (2023)

Multinational business finance /
por: Eiteman, David K.
Publicado: (2001)

Multinational business finance /
por: Eiteman, David K.
Publicado: (1998)

Multinational business finance /
por: Eiteman, David K.
Publicado: (1992)

The New Mission for Multinationals
por: Santos, José
Publicado: (2015)

Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence
por: Schechter, Meir, et al.
Publicado: (2021)

From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes
por: Mosenzon, Ofri, et al.
Publicado: (2021)

A Pneumococcal Carriage Study in Danish Pre-school Children before the Introduction of Pneumococcal Conjugate Vaccination
por: Harboe, Zitta B, et al.
Publicado: (2012)

Multinational enterprises and the global economy /
por: Dunning, John H.
Publicado: (1993)

International business and multinational enterprises
por: Robock, Stefan Hyman, 1915-
Publicado: (1989)

Multinational Corporation Subsidiaries in China
por: Zhao, Jinghua
Publicado: (2012)

Multinational enterprises and social policy
por: International Labour Office, Geneva
Publicado: (1973)

New multination project at CERN
por: CERN Press Office. Geneva
Publicado: (1967)

Technology and the multinationals : Corporate strategies in a changing world economy
por: Baranson, Jack
Publicado: (1979)

Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs
por: Cherney, David Z.I., et al.
Publicado: (2022)

Multinationals and transition : business strategies, technology, and transformation in Central and Eastern Europe /
por: Manea, Julia
Publicado: (2004)

Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study
por: Alguwaihes, Abdullah M.
Publicado: (2021)

Money in the multinational enterprise : a study of financial policy /
por: Robbins, Sidney M.
Publicado: (1974)

Managing the multinational enterprise : organization of the firm and ownership of the subsidiaries /
por: Stopford, John M.
Publicado: (1972)

Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis
por: Wilke, Thomas, et al.
Publicado: (2020)

Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: Efficacy and safety from a randomized double‐blind trial
por: Buse, John B., et al.
Publicado: (2018)

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4s4tfl0au11kah3mkeb92vn24u